Aerosol therapy in cystic fibrosis: A survey of 54 CF centers

Pediatric Pulmonology

Volumn 30, Issue 5, 2000, Pages 368-376

  Borsje, Petra ^a   De Jongste, Johan C ^a   Mouton, Johan W ^b   Tiddens, Harm A W M ^a  

^a SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^b CANISIUS WILHELMINA HOSPITAL   (Netherlands)

Author keywords

Aerosol therapy; Antibiotics; CF centers; Cystic fibrosis; Nebulizers; Physiotherapy; Survey

Indexed keywords

BRONCHODILATING AGENT; CEFTAZIDIME; CORTICOSTEROID; GENTAMICIN; MUCOLYTIC AGENT; NEOMYCIN; SODIUM CHLORIDE; TOBRAMYCIN;

ADULT; AGE DISTRIBUTION; ARTICLE; CHILD; CLEANING; CONTROLLED STUDY; CYSTIC FIBROSIS; DRUG COST; DRUG DELIVERY SYSTEM; DRUG EFFECT; HUMAN; INFANT; MAJOR CLINICAL STUDY; NEBULIZER; NEWBORN; PATIENT EDUCATION; PHYSICIAN ATTITUDE; PHYSIOTHERAPY; PRESCRIPTION; PRIORITY JOURNAL; TREATMENT PLANNING;

ADMINISTRATION, INHALATION; ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; AGE DISTRIBUTION; AGE FACTORS; BRONCHODILATOR AGENTS; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; CYSTIC FIBROSIS; DATA COLLECTION; EUROPE; EXPECTORANTS; HUMANS; INFANT; NEBULIZERS AND VAPORIZERS; NORTH AMERICA; PHYSICAL THERAPY MODALITIES; PHYSICIAN'S PRACTICE PATTERNS; QUESTIONNAIRES; SODIUM CHLORIDE;

EID: 0033764723     PISSN: 87556863     EISSN: None     Source Type: Journal    
DOI: 10.1002/1099-0496(200011)30:5<368::AID-PPUL2>3.0.CO;2-8     Document Type: Article

References (29)

1. The use of N-acetyl-L-cysteine in the treatment of cystic fibrosis
2. Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group
3. A longitudinal study of bronchodilator responsiveness in cystic fibrosis
4. A placebo-controlled, double-blind trial of the long-term effects of albuterol administration in patients with cystic fibrosis
5. Intermittent administration of inhaled tobramycin in patients with cystic fibrosis
6. Controlled trial of inhaled budesonide in patients with cystic fibrosis and chronic bronchopulmonary Pseudomonas aeruginosa infection
7. Effect of increasing doses of hypertonic saline on mucociliary clearance in patients with cystic fibrosis
8. A pilot study of aerosolized amiloride for the treatment of lung disease in cystic fibrosis
9. Sodium cromoglycate-induced changes in the dose-response curve of inhaled metacholine in cystic fibrosis
10. Early pulmonary inflammation in infants with cystic fibrosis
11. Lower airway inflammation in infants and young children with cystic fibrosis
12. The lung in cystic fibrosis; a quantitative study including prevalence of pathologic findings among different age groups
13. The influence of age on aerosol deposition in children with cystic fibrosis
14. Deposition pattern of radiolabeled salbutamol inhaled from a metered-dose inhaler by means of a spacer with mask in young children with airway obstruction
15. Acute and long-term amiloride inhalation in cystic fibrosis lung disease. A rational approach to cystic fibrosis therapy
16. Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid
17. No added benefit from nebulized amiloride in patients with cystic fibrosis
18. A double-blind placebo controlled trial with oral ambroxol and N-acetylcysteine for mucolytic treatment in cystic fibrosis
19. A controlled trial of long-term bronchodilator therapy in cystic fibrosis
20. Bronchial hyperreactivity in cystic fibrosis and asthma
21. Airway hyperreactivity in cystic fibrosis
22. Reduced effect of inhaled beta 2-adrenergic agonists on lung mucociliary clearance in patients with cystic fibrosis
23. Bronchodilators increase airway instability in cystic fibrosis
24. Efficacy of aerosolized tobramycin in patients with cystic fibrosis
25. Nebulised antipseudomonal therapy in cystic fibrosis
26. Nebuliser performance: AFLM study
27. In vitro comparison of deVilbiss jet and ultrasonic nebulizers
28. Problemen met gebruik, reiniging en onderhoud van vernevelapparatuur in de thuissituatie
29. Randomized controlled trials in cystic fibrosis (1966-1997) categorized by time, design, and intervention